Terms: = Liver cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546 AND Treatment
4 results:
1. Safety of pylorus-preserving gastrectomy for gastric cancer combined with antral high-risk lesions: a comparison with endoscopic submucosal dissection.
Choi J; Kim S; Chung H; Kong SH; Cho SJ; Park DJ; Lee HJ; Kim SG; Yang HK
Surg Endosc; 2023 Apr; 37(4):2987-2996. PubMed ID: 36517703
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of Non-tumoral liver Dose with treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
Webster LA; Villalobos A; Cheng B; Xing M; Majdalany BS; Bercu ZL; Cristescu MM; Brandon D; Schuster D; Baum Y; Loya MF; Kokabi N
Cardiovasc Intervent Radiol; 2023 Jan; 46(1):60-68. PubMed ID: 36450996
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract] [Full Text] [Related]
4. Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Naglieri E; Niccoli Asabella A; Nappi AG; Carella C; Ferrari C; Rubini G
Medicine (Baltimore); 2019 Dec; 98(50):e18093. PubMed ID: 31852068
[TBL] [Abstract] [Full Text] [Related]
